1. What is the condition?
Liver cancer is a malignancy of liver cells, most commonly hepatocellular carcinoma (HCC). It often develops on the background of cirrhosis or chronic fatty liver disease (NAFLD/NASH), though it can occasionally occur in NAFLD even without cirrhosis.
2. What are some common signs and symptoms?
– Often silent until late stage
– Abdominal pain or swelling
– Unexplained weight loss
– Jaundice (yellowing of skin or eyes)
– Typically found in patients with fatty liver, diabetes, or cirrhosis
3. What is the difference between the conventional view and the functional medicine perspective?
Conventional View:
Treatment depends on stage and liver function. Curative options include surgical resection, liver transplant, or local ablation. Intermediate stages are often treated with locoregional therapies such as TACE or TARE, while advanced cases may require systemic therapies, led today by immunotherapy and targeted tyrosine-kinase inhibitors. Classic chemotherapy is rarely used in HCC.
Functional View:
Many modern HCC cases are the downstream result of long-standing metabolic dysfunction — insulin resistance, fatty liver, and chronic inflammation — while viral hepatitis and alcohol-related pathways still play an important role worldwide.
4. How does the condition stem from metabolic dysfunction?
Liver cancer often follows a stepwise path: insulin resistance leads to fatty liver (NAFLD), which can progress to steatohepatitis (NASH), fibrosis, cirrhosis, and eventually HCC. Hyperinsulinemia amplifies insulin/IGF signaling, a potent growth pathway that promotes hepatocyte proliferation and tumor formation. Oxidative stress from excess fat damages DNA, creating mutations. Dysbiosis and leaky gut allow bacterial endotoxins (LPS) into the portal circulation, fueling inflammation and oncogenic signaling. Mitochondrial dysfunction limits the liver’s detoxification and resilience, further accelerating carcinogenesis.
5. Is there a solution?
Yes — the key is prevention by targeting the metabolic roots before cancer develops. Balance helps reduce post-meal glucose and insulin surges, supporting a slowdown in the NAFLD-to-NASH trajectory. Unimate provides polyphenols that may reduce oxidative stress and support mitochondrial function in liver cells. Lifestyle foundations — an anti-inflammatory diet, eliminating excess alcohol, weight reduction, and regular exercise — are essential for protecting liver health and lowering cancer risk.
Additional Functional Medicine Strategies:
– Omega-3 fatty acids, vitamin D, and curcumin to reduce liver inflammation
– Gut-healing protocols to lower endotoxin burden and support the gut-liver axis
– Intermittent fasting or time-restricted eating to improve fat oxidation and liver repair
7. Conclusion
Liver cancer today is often a metabolic cancer — the final stage of insulin resistance and fatty liver gone unchecked. By restoring metabolism, calming inflammation, and strengthening the gut-liver axis, you can reduce risk and protect your liver’s long-term health.
I’m Dr. Dieter, and I’m here to help you Reclaim Your Health.